Home UPDATE 2-AbbVie oral hep C drugs cure 96 pct in late stage trial
 

Keywords :   


UPDATE 2-AbbVie oral hep C drugs cure 96 pct in late stage trial

2013-12-11 01:07:56| Biotech - Topix.net

AbbVie Inc's all-oral hepatitis C therapy cured 96 percent of difficult-to-treat patients in a late-stage clinical trial after 12 weeks, keeping the company well placed in a highly competitive race to deliver new treatments for the serious liver disease.

Tags: update late stage trial

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11ProjectDIVAF
23.11MtG
23.11THUNDER TRUCKS HOLLOW II 148
23.11 the Tiger 7 EP
23.11 11 LEGACY
23.11 GENOCIDE
23.11HG PART1 PART2
More »